Want to see CCAP full AI Analyst Report?
CCAP Stock Chart & Stats
$13.58
-$0.14(-0.74%)
At close: 4:00 PM EST
$13.58
-$0.14(-0.74%)
Day’s Range― - ―
52-Week Range$10.77 - $16.04
Previous CloseN/A
Volume41.80K
Average Volume (3M)226.60K
Market Cap
$405.31M
Enterprise Value$1.30B
Total Cash (Recent Filing)$54.19M
Total Debt (Recent Filing)$907.13M
Price to Earnings (P/E)26.9
Beta0.60
Next Earnings
Aug 12, 2026EPS Estimate
0.37Next Dividend Ex-DateN/A
Dividend Yield13.2%
Share Statistics
EPS (TTM)0.41
Shares Outstanding36,845,950
10 Day Avg. Volume236,068
30 Day Avg. Volume226,601
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.74
Price to Sales (P/S)3.33
P/FCF Ratio6.97
Enterprise Value/Market Cap3.20
Enterprise Value/Revenue10.39
Enterprise Value/Gross Profit15.53
Enterprise Value/Ebitda25.41
Forecast
1Y Price Target
$13.75Price Target Upside1.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)1.56
Revenue Forecast (FY)$149.99M
Bulls Say, Bears Say
Bulls Say
Fee Structure ReductionLower permanent management and incentive fees reduce the structural drag on net investment income and align CCAP with lower-cost peers. This improves long-term earnings consistency and dividend sustainability by boosting retained distributable income and lowering sensitivity to funding spreads.
Improved Liquidity And Funding FlexibilityExpanded facilities, available capacity and planned ABL upsize materially enhance funding optionality and reduce near-term refinancing risk. Strong financing flexibility supports conservative deployment, portfolio management, and the ability to manage maturities without forcing sales in stressed markets.
Strong Cash GenerationConsistent operating cash flow and FCF alignment with net income indicate high earnings quality and good cash conversion. This durable cash generation supports regular dividends, funds conservative reinvestment, and provides a buffer against credit losses or episodic mark-to-market volatility.
Bears Say
Rising Credit Stress And ConcentrationAn uptick in nonaccruals, concentrated in health care and including legacy CCaaS positions, raises the risk of future realized losses and longer recovery timelines. Concentration in specific sectors can amplify volatility in earnings, NAV and provisioning needs, pressuring long-term distributable income.
NAV Volatility And QoQ DeclineMaterial quarterly NAV markdowns reflect market repricing and credit-specific depreciation. For a BDC, persistent NAV declines erode equity cushions, limit capital-raising ability, and can force more conservative deployment or higher reserves—weakening long-term return potential and dividend coverage.
Uneven Revenue And Core NII PressureDeclining core NII and negative TTM revenue growth signal weakening recurring earnings power. Reliance on waivers and special dividends to cover distributions highlights structural pressure on sustainable income, which may constrain long-term payout policy and limit organic portfolio growth.
Crescent Capital BDC News
CCAP FAQ
What was Crescent Capital Bdc, Inc.’s price range in the past 12 months?
Crescent Capital Bdc, Inc. lowest stock price was $10.77 and its highest was $16.04 in the past 12 months.
What is Crescent Capital Bdc, Inc.’s market cap?
Crescent Capital Bdc, Inc.’s market cap is $405.31M.
When is Crescent Capital Bdc, Inc.’s upcoming earnings report date?
Crescent Capital Bdc, Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 34 days.
How were Crescent Capital Bdc, Inc.’s earnings last quarter?
Crescent Capital Bdc, Inc. released its earnings results on May 13, 2026. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.419 by $0.001.
Is Crescent Capital Bdc, Inc. overvalued?
According to Wall Street analysts Crescent Capital Bdc, Inc.’s price is currently Undervalued.
Does Crescent Capital Bdc, Inc. pay dividends?
Crescent Capital Bdc, Inc. pays a Notavailable dividend of $0.03 which represents an annual dividend yield of 13.2%. See more information on Crescent Capital Bdc, Inc. dividends here
What is Crescent Capital Bdc, Inc.’s EPS estimate?
Crescent Capital Bdc, Inc.’s EPS estimate is 0.37.
How many shares outstanding does Crescent Capital Bdc, Inc. have?
Crescent Capital Bdc, Inc. has 36,845,950 shares outstanding.
What happened to Crescent Capital Bdc, Inc.’s price movement after its last earnings report?
Crescent Capital Bdc, Inc. reported an EPS of $0.42 in its last earnings report, beating expectations of $0.419. Following the earnings report the stock price went down -8.259%.
Which hedge fund is a major shareholder of Crescent Capital Bdc, Inc.?
Currently, no hedge funds are holding shares in CCAP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Crescent Capital BDC Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.75 (1.25% Upside)
$13.75 (1.25% Upside)
Blogger Sentiment
Bullish
CCAP Sentiment 70%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 30.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.98%
12-Months-Change
Fundamentals
Return on Equity
2.14%
Trailing 12-Months
Asset Growth
-2.93%
Trailing 12-Months
Company Description
Crescent Capital Bdc, Inc.
Crescent Capital BDC, Inc. functions as a Business Development Company (BDC), managing a fund dedicated to private equity, leveraged buyouts, and providing loan capital. The firm's strategy centers on making direct investments, with a specific focus on the middle market segment. Its investment mandate is exclusively for opportunities within the United States.
CCAP Company Deck
CCAP Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced mix of proactive, constructive strategic actions and ongoing credit challenges. Positives included permanent fee reductions to improve long-term earnings resilience, a reset dividend framework with special dividends to address spillover, solid liquidity and a robust platform pipeline, and continued portfolio-level metrics that remained largely stable (86% rated 1 or 2; interest coverage 2.2x). Offsetting these were meaningful near-term headwinds: NAV declined ~4.35% QoQ, core NII declined ~15.6% from the prior quarter (to $0.38 before the waiver), nonaccruals increased (to 5.7% of cost and 3.6% of fair value) with concentration in select health care assets, and leverage sat marginally above target. Management emphasized conservative mark-to-market practices and active portfolio management. Overall, the positives (structural fee/dividend changes, liquidity, deployment opportunities and platform strength) are balanced by credit-related pressures and earnings softness, resulting in a neutral near-term outlook but with steps aimed at longer-term stabilization.View all CCAP earnings summariesCCAP Stock 12 Month Forecast
Average Price Target
$13.75
▲(1.25% Upside)
Technical Analysis
Gladstone Capital
―
Gladstone Investment
―
Pennantpark Investment
―
BlackRock TCP Capital
―
CION Investment Corp
―
Ownership Overview
10.82% Insiders
1.06% Mutual Funds
0.18% Other Institutional Investors
83.82% Public Companies and
Individual Investors